MicroRNA-134 regulates lung cancer cell H69 growth and apoptosis by targeting WWOX gene and suppressing the ERK1/2 signaling pathway

Biochemical and Biophysical Research Communications

Volumn 464, Issue 3, 2015, Pages 748-754

  Chen, Tianjun ^a   Gao, Fei ^b   Feng, Sifang ^a   Yang, Tian ^a   Chen, Mingwei ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Hua Shan Centre Hospital   (China)

Author keywords

ERK1 2; MicroRNA 134; Small cell lung cancer; WWOX

Indexed keywords

LACTATE DEHYDROGENASE; MICRORNA; MICRORNA 134; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDOREDUCTASE; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG; WW DOMAIN CONTAINING OXIDOREDUCTASE; MIRN134 MICRORNA, HUMAN; RNA; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; WWOX PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMALL CELL LUNG CANCER; ANTAGONISTS AND INHIBITORS; GENETIC EPIGENESIS; GENETICS; LUNG TUMOR; METABOLISM; MOLECULAR MIMICRY; PATHOLOGY; PROGNOSIS; SMALL CELL CARCINOMA; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; EPIGENESIS, GENETIC; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MOLECULAR MIMICRY; OXIDOREDUCTASES; PROGNOSIS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84938745657     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.07.021     Document Type: Article

References (45)

1. N. Ilic, A. Petricevic, D. Arar, and et al. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer J. Thorac. Oncol. 2 2007 1018 1021
2. R.T. Greenlee, M.B. Hill-Harmon, T. Murray, and et al. Cancer statistics, 2001 CA Cancer J. Clin. 51 2001 15 36
3. C.F. Mountain Revisions in the international system for staging lung cancer Chest J. 111 1997 1710 1717
4. R. Govindan, N. Page, D. Morgensztern, and et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database J. Clin. Oncol. 24 2006 4539 4544
5. J. Brognard, A.S. Clark, Y. Ni, and et al. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation Cancer Res. 61 2001 3986 3997
6. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
7. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
8. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 6 2006 857 866
9. J. Li, Y. Wang, J. Luo, and et al. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells FEBS Lett. 586 2012 3761 3765
10. W.C. Cho MicroRNAs as therapeutic targets for lung cancer Expert Opin. Ther. Targets 14 2010 1005 1008
11. C.J. Liu, W.G. Shen, S.Y. Peng, and et al. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene Int. J. Cancer 134 2014 811 821
12. J. Li, J. Liu, Y. Ren, and et al. Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer Exp. Biol. Med. 2014 10.1177/1535370214561587
13. K. Ried, M. Finnis, L. Hobson, and et al. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells Hum. Mol. Genet. 9 2000 1651 1663
14. A.K. Bednarek, K.J. Laflin, R.L. Daniel, and et al. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23. 3-24.1, a region frequently affected in breast cancer Cancer Res. 60 2000 2140 2145
15. U. Lewandowska, M. Zelazowski, K. Seta, and et al. WWOX, the tumour suppressor gene affected in multiple cancers J. Physiol. Pharmacol. 60 2009 47 56
16. F.J. Pimenta, D.A. Gomes, P.F. Perdigão, and et al. Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas Int. J. Cancer 118 2006 1154 1158
17. R.I. Aqeilan, and C.M. Croce WWOX in biological control and tumorigenesis J. Cell. Physiol. 212 2007 307 310
18. S. Del Mare, Z. Salah, and R.I. Aqeilan WWOX: its genomics, partners, and functions J. Cell. Biochem. 108 2009 737 745
19. J.-Y. Chang, R.-Y. He, H.-P. Lin, and et al. Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase Exp. Biol. Med. 235 2010 796 804
20. R.I. Aqeilan, J.P. Hagan, H.A. Aqeilan, and et al. Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo Cancer Res. 67 2007 5606 5610
21. S. Del Mare, K.C. Kurek, G.S. Stein, and et al. Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma Am. J. Cancer Res. 1 2011 585
22. C. Gourley, A.J. Paige, K.J. Taylor, and et al. WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin α3 Cancer Res. 69 2009 4835 4842
23. N.-S. Chang, L.-J. Hsu, Y.-S. Lin, and et al. WW domain-containing oxidoreductase: a candidate tumor suppressor Trends Mol. Med. 13 2007 12 22
24. R.I. Aqeilan, Y. Pekarsky, J.J. Herrero, and et al. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog Proc. Natl. Acad. Sci. U. S. A. 101 2004 4401 4406
25. M. Abu-Remaileh, and R. Aqeilan Tumor suppressor WWOX regulates glucose metabolism via HIF1α modulation Cell Death Differ. 21 2014 1805 1814
26. V. Donati, G. Fontanini, M. Dell'Omodarme, and et al. WWOX expression in different histologic types and subtypes of non-small cell lung cancer Clin. Cancer Res. 13 2007 884 891
27. Z. Yulong, X. Yongjian, and Z. Zhenxiang Deletion and mutation of WWOX exons 6-8 in human non-small cell lung cancer J. Huazhong Univ. Sci. Technol. Med. Sci. 25 2005 162 165
28. D. Iliopoulos, G. Guler, S.-Y. Han, and et al. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer Oncogene 24 2005 1625 1633
29. R.K. Srivastava, A.B. Pant, M.P. Kashyap, and et al. Multi-walled carbon nanotubes induce oxidative stress and apoptosis in human lung cancer cell line-A549 Nanotoxicology 5 2011 195 207
30. D. Lobner Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J. Neurosci. Methods 96 2000 147 152
31. R. Hamano, H. Miyata, M. Yamasaki, and et al. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway Clin. Cancer Res. 17 2011 3029 3038
32. M. Fabbri, D. Iliopoulos, F. Trapasso, and et al. WWOX gene restoration prevents lung cancer growth in vitro and in vivo Proc. Natl. Acad. Sci. U. S. A. 102 2005 15611 15616
33. D. Iliopoulos, M. Fabbri, T. Druck, and et al. Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression Clin. Cancer Res. 13 2007 268 274
34. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method Methods 25 2001 402 408
35. S. Cho Tumor suppressor WWOX interacts with MEK2 and activates ERK pathway Bull. Korean Chem. Soc. 32 2011 2817 2819
36. G. Pearson, F. Robinson, T. Beers Gibson, and et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions 1 Endocr. Rev. 22 2001 153 183
37. J. Milanini, D.E. Richard, E. Berra, and et al. Signaling angiogenesis via p42/p44 MAP kinase cascade Ann. N. Y. Acad. Sci. 902 2000 187 200
38. E.J. Joslin, L.K. Opresko, A. Wells, and et al. EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation J. Cell Sci. 120 2007 3688 3699
39. Y. Karube, H. Tanaka, H. Osada, and et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients Cancer Sci. 96 2005 111 115
40. M. Garofalo, C. Quintavalle, G. Di Leva, and et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer Oncogene 27 2008 3845 3855
41. A. Navarro, T. Diaz, E. Gallardo, and et al. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer J. Surg. Oncol. 103 2011 411 415
42. L. Guo, Y. Liu, Y. Bai, and et al. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis Eur. J. Cancer 46 2010 1692 1702
43. X. Zhang, H. Wang, S. Zhang, and et al. MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation In Vitro Cell. Dev. Biol. Anim. 48 2012 131 136
44. C.S. Niu, Y. Yang, and C.-D. Cheng MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression Int. J. Oncol. 42 2013 1533 1540
45. S. Cory, and J.M. Adams The Bcl2 family: regulators of the cellular life-or-death switch Nat. Rev. Cancer 2 2002 647 656